X-Chem

Waltham, United States Founded: 2009 • Age: 17 yrs Acquired By Enko Chem
Small molecule drug discovery platform is provided to researchers.
Request Access

About X-Chem

X-Chem is a company based in Waltham (United States) founded in 2009 was acquired by Enko Chem in June 2022.. X-Chem has raised $8.5 million across 1 funding round from investors including PPD, Enko Chem and GHO Capital. The company has 51 employees as of December 31, 2022. X-Chem has completed 4 acquisitions, including Avisyn, ComInnex and Glamorous AI. X-Chem offers products and services including DEL Screening, ReadiDEL, ReadiBLOX, and ArtemisAI. X-Chem operates in a competitive market with competitors including STRmix, The Total Body Approach and DeepCodex, among others.

  • Headquarter Waltham, United States
  • Employees 51 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name X-Chem Inc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $8.5 M (USD)

    in 1 rounds

  • Latest Funding Round
    $8.5 M (USD), Series A

    Dec 21, 2012

  • Investors
    PPD

    & 2 more

  • Employee Count
    51

    as on Dec 31, 2022

  • Investments & Acquisitions
    Avisyn

    & 3 more

  • Acquired by
    Enko Chem

    & 2 more

    (Jun 15, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of X-Chem

X-Chem offers a comprehensive portfolio of products and services, including DEL Screening, ReadiDEL, ReadiBLOX, and ArtemisAI. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Service for screening DNA-encoded libraries to identify drug candidates.

Pre-built DNA-encoded library for rapid drug discovery research.

Modular building blocks for custom medicinal chemistry applications.

AI tool for analyzing molecular interactions in drug development.

People of X-Chem
Headcount 50-200
Employee Profiles 69
Employee Profiles
People
Sydney Peacock
Director Of Information Technology
People
Fabien Lindeperg
Research Scientist
People
Temilolu Idowu, PhD
Scientist
People
Taylor Hope
Research Scientist

Unlock access to complete

Funding Insights of X-Chem

X-Chem has successfully raised a total of $8.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.5 million completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $8.5M
  • First Round

    (21 Dec 2012)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2012 Amount Series A - X-Chem Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in X-Chem

X-Chem has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include PPD, Enko Chem and GHO Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Specialist healthcare investment advisory services are provided by GHO Capital.
Founded Year Domain Location
CRO providing diversified clinical development services
Founded Year Domain Location
Develops and supplies agriculture crop inputs
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by X-Chem

X-Chem has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Avisyn, ComInnex and Glamorous AI. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Preclinical studies for biopharma drug discovery are conducted.
2020
Scientific sourcing services are offered by Avisyn as a CRO.
2016
CRO offers synthetic, computational, analytical and in vitro and in vivo drug discovery services
2011
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - X-Chem

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

X-Chem Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of X-Chem

X-Chem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as STRmix, The Total Body Approach and DeepCodex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Develops software for forensic DNA profile analysis, interpretation, and evidence processing.
domain founded_year HQ Location
Music producer creating remixes, new releases, and podcasts for fan engagement.
domain founded_year HQ Location
Web app for searching gene expression data and genetic manipulations.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on X-Chem

Frequently Asked Questions about X-Chem

When was X-Chem founded?

X-Chem was founded in 2009 and raised its 1st funding round 3 years after it was founded.

Where is X-Chem located?

X-Chem is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.

Is X-Chem a funded company?

X-Chem is a funded company, having raised a total of $8.5M across 1 funding round to date. The company's 1st funding round was a Series A of $8.5M, raised on Dec 21, 2012.

How many employees does X-Chem have?

As of Dec 31, 2022, the latest employee count at X-Chem is 51.

What does X-Chem do?

X-Chem was founded in 2009 and is based in Waltham, United States. Operations center on a biotechnology platform for small molecule drug discovery, known as DNA-Encoded X-Chem (DEX). Libraries of small molecules tethered to DNA tags, which track synthetic history, are generated through combinatorial synthesis. These mixtures are screened via affinity binding to targets, with bound compounds detected by DNA sequencing for therapeutic development.

Who are the top competitors of X-Chem?

X-Chem's top competitors include STRmix, The Total Body Approach and DeepCodex.

What products or services does X-Chem offer?

X-Chem offers DEL Screening, ReadiDEL, ReadiBLOX, and ArtemisAI.

How many acquisitions has X-Chem made?

X-Chem has made 4 acquisitions, including Avisyn, ComInnex, and Glamorous AI.

Who are X-Chem's investors?

X-Chem has 3 investors. Key investors include PPD, Enko Chem, and GHO Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available